Phenoleptil

Quick links to important sections

Phenoleptil

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Phenoleptil

What is Phenoleptil?

Phenoleptil is a veterinary medicinal product used in the management of epilepsy in dogs. It belongs to a class of medications known as antiepileptics and contains the active substance phenobarbital.

Therapeutic Purpose

The primary purpose of this medication is to reduce the frequency and severity of seizures associated with idiopathic epilepsy. Idiopathic epilepsy is a condition characterized by recurrent seizures where no identifiable structural or metabolic cause is present. By stabilizing the electrical activity in the brain, the medication helps to control the onset of convulsive episodes.

Mechanism of Action

Phenobarbital, the active component, works by modulating specific neurotransmitters in the central nervous system. It primarily enhances the effect of gamma-aminobutyric acid (GABA), which is an inhibitory neurotransmitter. By increasing the inhibitory signals, the medication raises the seizure threshold, making the brain less susceptible to the disorganized electrical discharges that lead to seizures.

Available Forms

Phenoleptil is typically available in tablet form, often provided in multiple strengths to allow for precise adjustment based on the specific requirements of the animal. The tablets are often flavored to facilitate easier administration.

Regulatory References

  1. Phenobarbital - StatPearls - NIH
  2. Phenobarbital: MedlinePlus Drug Information

What side effects are possible with Phenoleptil?

Possible side effects and safety information

The safety profile of Phenoleptil (Phenobarbital) is structured around categories of adverse reactions explicitly documented in official government regulatory sources, classified by frequency and affected organ system.

Adverse effects predominantly involve the Nervous System and are often classified as Common or Very Common, particularly during the initial phase of treatment. These include drowsiness, sedation, ataxia (lack of coordination), dizziness, and lethargy. Paradoxical effects, such as excitement or hyperactivity, are specifically documented as adverse reactions in pediatric and older adult populations.

The official label documents rare, but Serious Adverse Reactions (SARs), including severe cutaneous adverse reactions such as Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN). Potential for significant liver toxicity (e.g., hepatitis) is also documented under Hepatobiliary Disorders.

Time- and Duration-Related Safety: Long-term use carries the regulatory-defined risk of developing physical and psychological dependence. The label also notes that continuous exposure may be associated with decreased bone mineral density, potentially leading to conditions like osteomalacia or rickets.

Safety Restrictions: Phenoleptil is subject to regulatory constraints, including being contraindicated in patients with severe hepatic insufficiency and acute intermittent porphyria. Abrupt cessation of the medication poses the high-level risk of precipitating a severe withdrawal syndrome.

Overdose and Emergency Response

Overdose and when to seek help

Overdose of Phenoleptil (Phenobarbital) is defined in regulatory documents by progressive, dose-dependent Central Nervous System (CNS) depression. Documented clinical manifestations range from drowsiness, confusion, slurred speech, and ataxia (staggering gait) to deep stupor and coma. In severe intoxication, there may be loss of brain stem reflexes and the presence of hypothermia.

The most critical documented risks are life-threatening respiratory depression (hypoventilation, apnea) and circulatory collapse (profound hypotension, shock syndrome). These severe outcomes necessitate immediate action.

All suspected overdoses require immediate medical attention. Emergency services must be contacted immediately if the individual is unconscious, has collapsed, or is experiencing trouble breathing. No specific antidote is known for Phenobarbital toxicity; therefore, management is symptomatic and supportive. This management involves maintaining airway patency, continuous monitoring of vital signs, and procedures such as administering activated charcoal and potentially extracorporeal removal techniques like hemodialysis for severe cases. The official labeling notes that uremia may increase CNS sensitivity to overdose effects.

Therapeutic Uses of Phenoleptil

What Phenoleptil Treats: Main Uses and Benefits

Phenoleptil is commonly used across conditions characterized by periods of heightened symptoms related to neurological function, such as seizure disorders. It is commonly used for managing chronic seizure disorders (epilepsy) and helps address symptom clusters that may become intense or disruptive, providing support that helps maintain a sense of stability when symptoms are more noticeable.


The therapeutic application of Phenoleptil is relevant for easing challenging symptoms across several key areas: it is used for managing recurrent seizure disorders (epilepsy), stabilizing acute neuronal crises like status epilepticus, and assisting with the management of pronounced symptoms during severe substance withdrawal syndromes. This medication supports the patient during difficult episodes by easing distress and providing a measure of symptomatic management.

“It is applied in clinical settings that involve acute or unstable symptom patterns, offering symptomatic relief that helps patients cope more steadily.”

This medication may assist with maintaining functional stability for patient groups ranging from neonates and infants through to adults, particularly when symptoms interfere with routine activities.


Quick Fact: Relief for Neurological Hyperexcitability This medication is often used during phases when symptoms become more noticeable due to symptoms of increased neurological activity, helping to reduce the potential for seizure recurrence.

Regulatory References

  1. National Institutes of Health (NIH) StatPearls overview

Eligibility and Restrictions for Use

Who Can and Cannot Use Phenoleptil (Phenobarbital)

Official regulatory documentation strictly defines the populations who can and cannot use Phenoleptil, based on specific physiological states and co-existing conditions.

Contraindicated Populations

Use of Phenoleptil is absolutely contraindicated in individuals with a known hypersensitivity to any barbiturate and in patients with a history of acute intermittent porphyria.

Absolute non-eligibility also applies to patients suffering from marked or severe impairment of liver function or those with severe respiratory depression or obstructive lung disease. Persons with a known previous addiction to sedative/hypnotic drugs must not use this medicine.

Conditional and Restricted Use

Category Eligibility Status Restriction/Condition
Age (Elderly) Use with Caution Increased risk of paradoxical excitement, depression, or confusion. Dosage typically requires reduction.
Organ Function Use with Caution Mandatory in patients with mild-to-moderate renal or hepatic impairment due to risk of accumulation.
Pregnancy Highly Restricted Generally not recommended; use only if benefits significantly outweigh risks, especially for women of childbearing potential.
Comorbidities Use with Caution Necessary for patients with uncontrolled diabetes mellitus, severe anemia, or borderline hypoadrenal function.

What should I know about interactions with other medicines?

Phenoleptil's active substance, Phenobarbital, is a strong inducer of hepatic cytochrome P450 enzymes. This pharmacokinetic interaction necessitates careful monitoring, as co-administration may decrease the activity and plasma concentrations of numerous other medicinal products.

Drug–Drug Interactions

The induction of hepatic enzymes reduces the efficacy of products like Oral Anticoagulants (such as Warfarin), Corticosteroids, and Oral Contraceptives, and shortens the half-life of Doxycycline. Conversely, co-administration with Valproic Acid or Monoamine Oxidase Inhibitors (MAOIs) is documented to increase phenobarbital serum levels due to the inhibition of its metabolism, which may require clinical attention. Furthermore, Phenobarbital interferes with the gastrointestinal absorption of medicines like Griseofulvin, leading to a decrease in its measured blood level.

Pharmacodynamic and Substance Interactions

A significant pharmacodynamic interaction occurs with Alcohol and other Central Nervous System (CNS) depressants, including tranquilizers and sedatives. The combination of these substances may produce additive depressant effects. Regulatory documents note that these additive effects are officially recognized as being more pronounced in elderly patients. Co-administration with herbal products containing St. John's Wort should be avoided due to the documented risk of enzyme induction that reduces Phenoleptil's efficacy. Use is strictly contraindicated in patients with a history of manifest or latent acute porphyrias.

Mechanism of Action

How Phenoleptil Works

Phenoleptil's active ingredient, Phenobarbital, uses a dual mechanistic action within the Central Nervous System (CNS) to modulate neuronal hyperexcitability. This action is rooted in two primary domains that collectively increase inhibition and suppress excitation.

Positive Modulation of Inhibitory Receptors

This domain covers the drug's principal action on the GABAA receptor, the key molecular target for inhibitory signaling. Phenobarbital acts as a positive allosteric modulator, binding to the receptor complex and greatly prolonging the duration of the chloride ion ( Cl^-) channel opening. This causes a massive influx of negative Cl^- ions, leading to hyperpolarization of the postsynaptic neuron. The physiological consequence of this is an elevation of the electrical firing threshold, reducing the neuron's responsiveness to excitatory stimuli.

Direct Suppression of Excitatory Channels

This domain describes the drug's secondary mechanism: the suppression of fast excitatory transmission. Phenobarbital directly inhibits voltage-dependent sodium ( Na^+) channels and certain high-voltage activated calcium ( Ca^2+) channels. This action limits the ability of nerve cells to rapidly depolarize and successfully propagate electrical signals. This secondary suppression of the electrical current complements the primary inhibitory action, resulting in a generalized reduction in CNS excitability.

️ Mechanistic Constraints

The drug's mechanism is physiologically constrained and generally does not effectively suppress the specific thalamocortical circuit activity driving certain rhythmic neuronal discharge patterns. Furthermore, continuous engagement of the GABAA receptor can lead to mechanistic tolerance, requiring the biological system to adapt to the drug's constant presence to sustain the enhanced inhibitory tone.

Dosage and Administration Information

Phenoleptil (Phenobarbital) is a prescription-only medicine used strictly according to specific guidelines that define its administration. The choice of route depends on the required speed of action. For chronic conditions, the primary route is oral (PO), typically using tablets or the liquid solution. For acute, time-sensitive situations, the intravenous (IV) or intramuscular (IM) routes are officially approved for utilization in a closely supervised setting.


Administration Guidelines

Element Official Use Parameter
Dosing Schedule Adult maintenance doses typically range from 60 mg to 200 mg per day. Acute parenteral loading doses may be up to 20 mg/kg of body weight.
Frequency Due to its long half-life, the daily dose is often administered once daily, frequently at bedtime, or in 2 to 3 divided doses.
Special Procedures IV administration must be performed slowly, generally not exceeding 60 mg per minute in adults. The liquid solution must be measured with a calibrated device for accuracy.
Population Rules Pediatric doses are weight-based (e.g., 3 to 8 mg/kg/day). Older adults require a reduced initial dosage.

Use Over Time

Phenoleptil is intended for long-term therapy and must never be stopped abruptly. The official protocol mandates that the dose must be gradually tapered over a period of time to prevent the potential for acute seizure activity. The medication may be taken with or without food. If a dose is missed, patients should follow their specific instructions, generally avoiding a double dose.

Recent Clinical Evidence

Phenoleptil: Research Evidence Overview

This overview summarizes the formal clinical research that has been conducted on Phenoleptil (Phenobarbital), describing the types of studies that exist, the outcomes they measured, and what remains unclear in the available research. This information is intended for context only and is not medical advice or a substitute for professional clinical guidance.


Evidence for Use in Managing Recurrent Seizure Disorders

Research for the long-term management of chronic seizures has involved Randomized Controlled Trials (RCTs) and long-term observational cohort studies. The primary goals of these investigations were to monitor changes in seizure frequency and to measure the rate of achieving seizure-free status. Studies also examined outcomes such as measures of cognitive ability and overall daily functioning over time.

Findings describe patterns observed related to these endpoints. However, the evidence is not uniformly conclusive; the methodological quality of a significant portion of the historical RCTs varies across studies, and findings were mixed regarding long-term neurodevelopmental endpoints in children. The evidence reflects a lack of recent comparative studies against the newest available treatments.


Evidence for Use in Acute Neuronal Crises

Research exploring use during severe neurological events, such as status epilepticus, identified few Randomized Controlled Trials (RCTs) and includes non-randomized retrospective studies in critical care settings. Studies monitored a primary goal of achieving rapid seizure cessation and reducing seizure recurrence. Research indicates a high degree of variability in drug processing among critically ill patient populations.

A key uncertainty is the low volume of modern RCTs providing direct evidence for the drug's role early in these crises, with most research coming from observational studies of refractory cases. Existing studies often provide limited insight into long-term neurological recovery.


What Research Gaps and Uncertainty Remain

The evidence quality varies across studies, with older clinical trials often having follow-up durations that were limited. Comparative evidence is lacking for many direct comparisons against the newest generation of anti-seizure medications. Furthermore, data for certain groups remain insufficient, especially for older adults. The existing research provides context about group patterns, not individual predictions.

Key Studies & References Guideline for the Evaluation and Management of Status Epilepticus (American Academy of Neurology/Neurocritical Care Society)

Frequently Asked Questions (FAQ)

Common questions about Phenoleptil (FAQ)

Q: Does Phenoleptil need to be taken with food?

A: Official information indicates that Phenoleptil can generally be taken with or without food. However, absorption into the bloodstream may be slightly faster when the medication is taken on an empty stomach.


Q: What happens if I miss a dose of Phenoleptil?

A: According to official product information, general guidelines state that if a dose is missed, it should be taken as soon as it is remembered. If it is almost time for the next scheduled dose, the missed dose is typically skipped, with the instruction to avoid taking a double dose.


Q: What are the common side effects of Phenoleptil that I should watch out for?

A: Common side effects listed in official labeling include feeling drowsy, dizzy, or uncoordinated (ataxia), as well as headache, nausea, and vomiting. Serious adverse reactions that have been documented include severe blistering skin rashes or difficulty breathing, which are considered signs for immediate concern.


Q: Does Phenoleptil interact with common pain relievers?

A: Regulatory documents indicate that Phenoleptil can interact with the common pain reliever acetaminophen. This combination may potentially alter the effects of acetaminophen and increase the risk of liver side effects. Phenoleptil may also combine with other central nervous system depressants, potentially leading to increased sedative effects.


Q: Are there any supplements that shouldn't be taken with Phenoleptil?

A: Regulatory documents indicate a documented risk when taking supplements like St. John's Wort, as it may decrease the effectiveness of Phenoleptil. Also, combining it with sedative herbs such as Kava or Valerian can potentially increase the drowsy side effects.


Q: Is Phenoleptil safe for long-term use?

A: Phenoleptil is primarily intended for long-term therapy to control seizures. Regulatory warnings state that continuous use carries documented risks, including the potential for tolerance, dependence, and decreased bone mineral density.


Q: Is there a generic version of Phenoleptil available?

A: Yes, the active ingredient in Phenoleptil, which is phenobarbital, is available in generic form. Generic versions are offered in various formulations.


Q: Is it okay to drink coffee while taking Phenoleptil?

A: No direct warning about coffee consumption is found in official labeling. However, caffeine is a Central Nervous System (CNS) stimulant, and Phenoleptil is a CNS depressant, which may lead to opposing pharmacological effects.


Q: What are the potential side effects on skin from Phenoleptil?

A: The most serious, though rare, potential skin side effects documented in the official labeling include severe reactions like Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN). Other less severe signs of hypersensitivity, such as localized swelling or dermatitis, may also be noted.


Q: Does Phenoleptil lose its effectiveness over time?

A: Official information mentions that tolerance can develop with continued use, particularly for the sedative and hypnotic (sleep-inducing) effects. This may lead to a perceived loss of effectiveness over time.


Q: What are the withdrawal symptoms if Phenoleptil is stopped suddenly?

A: Regulatory warnings state that abrupt cessation after prolonged use can lead to a severe withdrawal syndrome in a dependent person. Symptoms may include delirium, convulsions (seizures), insomnia, and nightmares.


Q: Is Phenoleptil commonly used in older patients?

A: Yes, Phenoleptil is used in older patients, but regulatory documents advise that caution is necessary. Older individuals may have an increased risk of paradoxical excitement, confusion, and additive depressant effects on the Central Nervous System (CNS).


Q: Does Phenoleptil have any known interactions with herbal teas?

A: Awareness of the ingredients in herbal teas is important, as the official label specifically warns against the use of St. John's Wort due to its potential to reduce medication effectiveness. Teas containing sedative or stimulant properties may also have additive or opposing effects.


Q: Can taking too much Phenoleptil cause serious problems?

A: Yes, overdosage with Phenoleptil is documented to cause serious problems. Official documents list signs of severe Central Nervous System and respiratory depression, hypotension, coma, and circulatory collapse.


Q: What are the signs of Phenoleptil toxicity?

A: Signs of toxicity, or overdose, include severe drowsiness and confusion, very slowed breathing, a significant loss of physical coordination (ataxia), and, in severe cases, coma. These signs are documented in overdose scenarios and indicate the need for prompt management.


Q: Can Phenoleptil affect coordination?

A: Yes, according to adverse reaction data, Phenoleptil is commonly associated with a lack of coordination, known as ataxia, and dizziness. These effects may impact physical steadiness and balance.


Q: Are there any dietary restrictions specific to Phenoleptil?

A: Aside from the strong regulatory warning to avoid alcohol due to additive depressant effects, there are generally no specific dietary restrictions, and the medication can be taken with or without food.


Q: Why do some people experience mood swings on Phenoleptil?

A: Official labeling documents Phenobarbital as a Central Nervous System (CNS) depressant that can cause emotional disturbances. These effects may be observed as phobias, sadness (depression), or, paradoxically, excitement in certain individuals.


Q: Does Phenoleptil affect contraception effectiveness?

A: Yes. Regulatory documents explicitly state that Phenoleptil can decrease the activity and effectiveness of oral contraceptives by acting as an enzyme inducer in the liver. This can lower the concentration of the contraceptive medication in the bloodstream.


Q: Do children respond differently to Phenoleptil than adults?

A: Yes, official information notes that children may have different responses than adults. They can sometimes experience a paradoxical reaction, such as hyperactivity or irritability, rather than sedation. Dosing is also specially calculated based on the child's weight.


Q: Can Phenoleptil interact with cold and flu remedies?

A: Cold and flu remedies often contain ingredients that may interact with Phenoleptil. For instance, they may contain antihistamines (which are CNS depressants that can increase drowsiness) or ingredients that affect the metabolism of Phenoleptil.


Q: Does Phenoleptil have any effect on memory?

A: Official reports indicate that Phenoleptil has been associated with cognitive deficits (problems with thinking and learning) in children. The medication can also cause impairment in thinking and psychiatric disturbance in adults.

How should Phenoleptil be stored and disposed of?

How to Store and Dispose of Phenoleptil

The storage and disposal of Phenoleptil (phenobarbital) must adhere strictly to regulatory requirements to maintain product stability and ensure safety.


Mandatory Storage Requirements

Condition Requirement
Temperature Store at Controlled Room Temperature (20 C to 25 C / 68 F to 77 F).
Protection Must be protected from light and protected from moisture.
Container Dispensed in a tight, light-resistant container with a child-resistant closure.
Safety Must be kept out of the sight and reach of children.

Disposal Instructions

Phenoleptil must be disposed of according to local regulations for pharmaceutical waste. As a controlled substance, the preferred method is a drug take-back program. If a take-back option is unavailable, the product is listed as a medicine that may be flushed down the toilet to prevent accidental ingestion.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Phenoleptil found in:

A-Z Index: